報告:
O'B Hourihane, J., Beyer, K., Abbas, A., Fernández-Rivas, M., Turner, P.J., Blumchen, K., ... & du Toit, G. (2020). Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial.
The Lancet Child & Adolescent Health, Published Online. DOI:
10.1016/S2352-4642(20)30234-0